E. coli β-agarase Production for High-Purity Neoagarotetraose

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing agarase encounter difficulties such as insufficient production, unstable production, safety concerns, and high production costs, limiting the industrial application of agarase-derived oligosaccharides, which are valuable for their physiological and biological activities.

Innovation Solution

A novel β-agarase is developed using a prokaryotic cell expression system, specifically an E. coli gene expression system, to produce agarase efficiently and stably, enabling the hydrolysis of agarose to obtain high-purity neoagarotetraose with reduced production costs.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional microorganisms are used to produce agarase, then agarase production can be achieved, but the production is insufficient and unstable

Engineering Contradiction:
Improveagarase production amountVSAvoidproduction stability
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent optimizes multiple parameters including induction temperature (16-37°C), induction time (4-72 hours), and culture conditions to achieve stable and sufficient agarase production. The specific parameters of inducing at 20-30°C for 24-72 hours were determined through systematic experimentation to maximize both yield and consistency.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs monitoring and optimization of production parameters based on measured agarase activity. By measuring enzyme activity at different time points and conditions, the process parameters are adjusted to maintain optimal production levels and ensure batch-to-batch consistency.

Inventive Principle:
Principle #23Feedback

2Productivity

If conventional microorganisms are used to produce agarase, then agarase production can be achieved, but safety concerns arise

Engineering Contradiction:
Improveagarase production amountVSAvoidsafety concerns
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent uses E. coli as a temporary expression system that can be easily cultured and disposed of. The bacterial cells serve as disposable factories for producing agarase, which is then purified from the culture medium, eliminating the need for complex containment procedures required with pathogenic organisms.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Productivity

If conventional methods are used to produce agarase, then agarase can be obtained, but production cost is high

Engineering Contradiction:
Improveagarase production amountVSAvoidproduction cost
Core Design Contradiction:
ProductivityVSEase of manufacture

Solution Approach 1:

The patent utilizes the E. coli cell's own protein synthesis machinery to produce agarase after introducing the recombinant plasmid. The bacteria naturally perform transcription and translation, eliminating the need for complex in vitro synthesis equipment and reducing production costs.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent optimizes induction conditions (temperature, time, IPTG concentration) to maximize agarase yield while minimizing culture time and resource consumption. The optimized parameters reduce overall production cost by achieving high titers in shorter cultivation periods.

Inventive Principle:
Principle #35Parameter changes

4Quantity of substance

If acid hydrolysis method is used to obtain oligosaccharide, then agaro-oligosaccharide mixture can be obtained, but products with uniform degree of polymerization cannot be obtained

Engineering Contradiction:
Improveoligosaccharide productionVSAvoiddegree of polymerization uniformity
Core Design Contradiction:
Quantity of substanceVSManufacturing precision

Solution Approach 1:

The patent replaces chemical acid hydrolysis with enzymatic hydrolysis using agarase. The enzyme provides selective catalysis that cleaves agarose at specific positions, yielding oligosaccharides with controlled and uniform degree of polymerization, primarily neoagarotetraose and neoagarohexaose.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces agarase enzyme as an intermediary catalyst between agarose substrate and oligosaccharide product. This enzymatic intermediary enables controlled hydrolysis with high selectivity, producing uniform oligosaccharide products that cannot be achieved through direct acid hydrolysis.

Inventive Principle:
Principle #24Intermediary (Mediator)

5Manufacturing precision

If enzymatic hydrolysis is used instead of acid hydrolysis, then selective cutting of glycosidic linkages can be achieved, but additional process steps are required

Engineering Contradiction:
Improveoligosaccharide selectivityVSAvoidprocess complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent replaces complex chemical processes (acid hydrolysis requiring neutralization and desalination) with a simpler enzymatic process. Although enzyme production requires fermentation, the hydrolysis step itself is simpler, requiring only mild conditions without additional chemical treatment steps.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method achieves high-purity neoagarotetraose production with reduced costs and improved stability, facilitating industrial applications by utilizing the E. coli expression system to produce β-agarase, which hydrolyzes agarose effectively and efficiently, overcoming previous production challenges.

Implementation Method 1

β-agarase hydrolyzes at the β-1,4 glycosidic linkage of agarose and agaropectin and results in neoagaro-oligosaccharides

Methodology Applied
Scientific EffectEnzymatic hydrolysis: Hydrolysis

Implementation Method 2

β-agarase (EC 3.2.1.81)

Methodology Applied
Scientific EffectEnzyme: Enzyme

Data Source

PatentUS9683223B2Agarase, composition containing the same, and application thereof
Publication Date: 2017.06.20 AGRICULTURAL TECHNOLOGY RESEARCH INSTITUTE
  • US9683223B2 patent drawing
  • US9683223B2 patent drawing
  • US9683223B2 patent drawing

AI summary

The present invention provides a β-agarase, a composition containing the same and applications thereof. The present β-agarase provides the field a novel alternative and is favorable for the industrial utilities of the hydrolysis products of agarose. Furthermore, the hydrolysis product of agarose by the present β-agarase has high purity of neoagarotetraose therefore the present β-agarase is especially useful for the neoagarotetraose's utilities in the field.